Parexel principles for artificial intelligence (AI)
Parexel is committed to the development of innovative, high-value, high-quality use cases for AI. We believe AI provides tools to help manage the increasing complexity of clinical development, including opportunities to expedite development timelines for products to reach patients quicker.
Here we outline our six principles for how Parexel conceives, develops, deploys, and monitors AI applications intended for use in clinical development and throughout our business.
Related Insights
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Membership in Clinical Research Data Sharing Alliance enables Parexel to shape the future of clinical trial data
Sep 7, 2022
Blog
PBPK modeling solutions as a potential risk mitigation strategy for pH dependent DDIs
Mar 15, 2021
Blog
Putting AI to work in your safety program
May 21, 2021
Blog
RBQM is our future: Using holistic risk-based oversight, we can focus on a trial’s most critical factors
Jun 18, 2021
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Article
Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?
Aug 6, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Clinical pharmacology, modeling and simulation to support FIH study design
Oct 21, 2021
Blog
CNS Summit Recap: The Future is Collaborative
Nov 22, 2021
Related Insights
Article
Human-in-the loop AI: a proven approach to streamlining PV case processing and review
Oct 7, 2024
Blog
Membership in Clinical Research Data Sharing Alliance enables Parexel to shape the future of clinical trial data
Sep 7, 2022
Blog
PBPK modeling solutions as a potential risk mitigation strategy for pH dependent DDIs
Mar 15, 2021
Blog
Putting AI to work in your safety program
May 21, 2021
Blog
RBQM is our future: Using holistic risk-based oversight, we can focus on a trial’s most critical factors
Jun 18, 2021
Article
Tencent-Backed Wedoctor Is Going Public: What Are the Next Steps for Chinese Digital Health Companies?
Jun 30, 2021
Article
Evidence Generation Strategy under Germany’s Digital Healthcare: Is More Better?
Aug 6, 2021
Blog
Highlights from ISMPP Asia Pacific Meeting 2021
Sep 20, 2021
Blog
Capitalizing on sensors in clinical trials
Sep 20, 2021
Blog
Actigraphy advances a patient-first approach: Reduce patient burden — and make the most of valuable data
Oct 15, 2021
Blog
Clinical pharmacology, modeling and simulation to support FIH study design
Oct 21, 2021
Blog
CNS Summit Recap: The Future is Collaborative
Nov 22, 2021